View in EDS PDF Full Text

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

Saved in:
Bibliographic Details
Title: Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
Authors: Asselah, Tarik1 tarik.asselah@aphp.fr, Moreno, Christophe2, Sarrazin, Christoph3, Gschwantler, Michael4, Foster, Graham R.5, Craxí, Antonio6, Buggisch, Peter7, Sanai, Faisal8, Bicer, Ceyhun9, Lenz, Oliver9, Van Dooren, Gino9, Nalpas, Catherine10, Lonjon-Domanec, Isabelle10, Schlag, Michael11, Buti, Maria12
Source: PLoS ONE. 1/5/2017, Vol. 12 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Description
ISSN:19326203
DOI:10.1371/journal.pone.0168713